About Us
Get winning Stock, Option and Cryptocurrency trade ideas from pro-traders. Follow their strategies, see how they perform.
|
|
|
MYL - Mylan N.V.| Previous Close | $14.83 | Open | $14.84 |
| Volume | 4.54M | Market Cap | 7.532B |
| Yield | Last Dividend |
| Global Reversible Airway Diseases Treatm... | 1:12 AM |
| Data Bridge Market Research has provides the Qualitative and informative knowledge by adding titled ???Global Reversible Airway Diseases Treatment Mar... | |
| Carboplatin Market In-Depth Analysis Of ... | 09/30/20 |
| Los Angeles, United State, ??? ??? QY Research recently added a research report, Global Carboplatin Market Research Report 2020 to its ever-increasing... | |
| Drug Addiction Treatment Market Strategi... | 09/30/20 |
| The Global Drug Addiction Treatment Market research study takes a comprehensive approach towards studying the key trends influencing the growth of thi... | |
| Outstanding Growth of Opioids Drug Marke... | 09/29/20 |
| Global Opioids Drug Market Synopsis: The Opioids Drug Market has also suffered a certain impact, but still maintained a relatively optimistic growth, ... | |
| Calcium Folinate Market 2020: Growing De... | 09/28/20 |
| The Calcium Folinate market 2020 research report is a detailed view of market opportunity by end-user segments, product Type segments, sales channels,... | |
| Uzbekistan and specific city Tashkent An... | 09/28/20 |
| Los Angeles, United State, ??? ??? QY Research recently added a research report, Global Hydroxychloroquine for COVID-19 Market Research Report 2020 to... | |
| Rituximab Biosimilars Market Is Booming ... | 09/28/20 |
| The Business Research Company offers "Rituximab Biosimilars Global Market Report 2020-30: COVID-19 Growth And Change" in its research report store. It... | |
| Global Clinical Stage Partnering Terms a... | 09/18/20 |
| DUBLIN , Sept. 18, 2020 /PRNewswire/ -- The "Global Clinical Stage Partnering Terms and Agreements in Pharma and Biotech 2014-2020" report has been ad... | |
| Mylan and Pfizer Receive European Commis... | 09/15/20 |
| HERTFORDSHIRE, England, PITTSBURGH and NEW YORK, Sept. 15, 2020 /PRNewswire/ -- Mylan (NASDAQ: MYL) and Pfizer Inc. (NYSE: PFE) today announced that t... | |
| Mylan to Present at the Morgan Stanley V... | 09/09/20 |
| HERTFORDSHIRE, England and PITTSBURGH, Sept. 9, 2020 /PRNewswire/ -- Global pharmaceutical company Mylan N.V. (NASDAQ: MYL) today announced that Execu... | |
| Mylan to Present at the BofA Securities ... | 09/09/20 |
| HERTFORDSHIRE, England and PITTSBURGH, Sept. 9, 2020 /PRNewswire/ -- Global pharmaceutical company Mylan N.V. (NASDAQ: MYL) today announced that Execu... | |
| S.African drugmaker Aspen sells thrombos... | 09/08/20 |
| South African drugmaker Aspen Pharmacare said on Tuesday it had sold its European thrombosis business to U.S. pharmaceutical company Mylan for almost ... | |
| Glargine launch in US opens up a huge op... | 08/31/20 |
| Even as a biosimilar, it is estimated to be a $2.2-billion opportunity for Biocon and Mylan. | |
| Mylan launches low-cost biosimilar insul... | 08/31/20 |
| ???I hate to say it, but [any savings] depends on if and how a patient is insured,??? Stacie Dusetzina, a health policy expert at Vanderbilt Universit... | |
| Pharmaceutical Companies Are Doing Much ... | 08/31/20 |
| The merger of Pfizer's Upjohn business with Mylan NV (NASDAQ: MYL ), along with the potential of its COVID-19 vaccine candidate that it's developing w... | |
| Biocon-Mylan launch insulin Glargine at ... | 08/31/20 |
| The commercialisation in the US of the drug, which already has approval in 45 countries, gives a boost to Biocon's ambitious target of $1 billion in s... | |
| Biocon Biologics launches Semglee, drug ... | 08/31/20 |
| BENGALURU: Biocon Biologics, a subsidiary of Biocon, and Mylan have launched Semglee (insulin glargine injection) in vial and pre-filled pen presentat... | |
| Mylan and Biocon Biologics Announce Laun... | 08/31/20 |
| HERTFORDSHIRE, England and PITTSBURGH and BENGALURU, India, Aug. 31, 2020 /PRNewswire/ -- Mylan N.V. (NASDAQ: MYL) and Biocon Biologics India Ltd., a ... | |
| Mylan Initiates Voluntary Nationwide Rec... | 08/28/20 |
| HERTFORDSHIRE, England and PITTSBURGH, Aug. 28, 2020 /PRNewswire/ -- Mylan N.V. (NASDAQ: MYL) today announced that its U.S.-based Mylan Institutional ... | |
| Zydus Cadilla announces Remdac, the chea... | 08/13/20 |
| Ahmedabad: Zydus Cadilla, the city based pharmaceutical major, has introduced India's cheapest version of Remdesivir. In a drug filing notification, Z... | |
| India's cheapest remdesivir is here | 08/13/20 |
| BENGALURU: Zydus Cadila on Thursday launched the cheapest generic version of Gilead Sciences' antiviral drug remdesivir in India to treat COVID-19 fol... | |
| Mylan N : ROSEN, A GLOBALLY RECOGNIZED F... | 08/12/20 |
| NEW YORK, Aug. 12, 2020 /PRNewswire/ -- Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Mylan N.V. between ... | |
| Mylan N : ROSEN, A LONGSTANDING AND TRUS... | 08/09/20 |
| Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Mylan N.V. between February 16, 2016 and May 7, 2019, inclu... | |
| EpiPen purchasers can't sue PBMs over pr... | 08/06/20 |
| A federal judge has declined to certify four classes of EpiPen purchasers to pursue claims that pharmacy benefit managers' pursuit of rebates and othe... | |
| Mylan narrows full-year revenue estimate... | 08/06/20 |
| Mylan NV on Thursday lowered the top-end of its full-year sales estimate as the drugmaker predicted a slower-than-expected recovery from the COVID-19 ... | |
| Mylan Earnings Beat, Revenue Misses In Q... | 08/06/20 |
| https://www.investing.com/news/stock-market-news/mylan-earnings-beat-revenue-misses-in-q2-2256285 | |
| Mylan posts quarterly profit compared to... | 08/06/20 |
| Aug 6 (Reuters) - Mylan NV reported a second-quarter profit on Thursday, helped in part by strong sales of its newly launched products such as asthma ... | |
| Mylan posts quarterly profit compared to... | 08/06/20 |
| Mylan NV reported a second-quarter profit on Thursday, helped in part by strong sales of its newly launched products such as asthma drug Wixela. The d... | |
| Mylan Reports Strong Second Quarter and ... | 08/06/20 |
| HERTFORDSHIRE, England and PITTSBURGH, Aug. 6, 2020 /PRNewswire/ -- Mylan N.V. (NASDAQ: MYL) today announced its financial results for the three and s... | |
| Worldwide Oral Antibiotics Industry to 2... | 08/05/20 |
| DUBLIN--(BUSINESS WIRE)--The "Oral Antibiotics Market, by Class, Application, Drug Origin, Spectrum of Activity and Drug Type: Global Opportunity Anal... | |
| Hold rating | 08/11/20 |
| UBS maintains Neutral rating and raises Price Target from $17.00 to $18.00 | |
| Date | 2020-08-06 (BMO) | Est. (EPS/Rev.) | $0.98/ 2.75B |
| Actual (EPS/Rev.) | $1.11/ $2.73 B | EPS (TTM) | 0 |
| Total Revenue | $1.3B | Total Liabilities | $2.1B |
| Cost of Revenue | $2.5B | Total cash flow | $3.2 |
| Total Assets | $29.98B |
| % Insider | 12.52% | % Institutional | 76.43% |
| Vanguard | 12.52% (+6.4%) | Bank of America | 10.43% |
| Vanguard | 12.52% (+6.4%) | Bank of America | 10.43% |
| Vanguard | 12.52% (+6.4%) | Bank of America | 10.43% |
| Vanguard | 12.52% (+6.4%) | Bank of America | 10.43% |
| Vanguard | 12.52% (+6.4%) | Bank of America | 10.43% |
| Service Name | Trader | % Success | |
|---|---|---|---|
| The profit machine | Gino Baldassano | 70.00 % | Follow |
| Alpha Swing Trades | Jonathan | 68.00 % | Follow |
| Options Edge | Calvin Moore | 62.00 % | Subscribe |
| TopFlight Trades - Premium (Options) | Eric Cunningham | 51.00 % | Follow |
| Options Mann | Thomas Mann | 40.00 % | Follow |
Get winning Stock, Option and Cryptocurrency trade ideas from pro-traders. Follow their strategies, see how they perform.
We are not a registered investment advisor. All investments involve risk, individual's trading does not guarantee future results or returns. Investors are fully responsible for any investment decisions they make. References to specific securities should not be construed as a recommendation to buy or sell that security only mentioned for informational purposes.
